DOI: 10.1001/jamainternmed.2026.4520 ISSN: 2168-6106
Policy and Design Considerations for Most-Favored-Nation Drug Pricing
Matthew Vogel, Olivier J. WoutersThis Viewpoint discusses most-favored-nation drug pricing and how to strengthen this type of drug pricing in Medicare.